High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics
Clinical Genetics · 2026
DOI: 10.1111/cge.70079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Rivka Birnbaum und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Hadassah Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Exome Sequencing, Oligonucleotide Array Sequence Analysis, Microarray Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Exome sequencing (ES), originally developed to detect single nucleotide variants (SNVs), has been increasingly leveraged to detect copy number variants (CNVs) through read‐depth analysis, enhancing diagnostic yield with minimal computational overhead. However, chromosomal microarray (CMA) testing remains widely used. To evaluate the utility of ES as a first‐tier clinical diagnostic test, we compared the sensitivity of CNV detection by ES to that of CMA in individuals who underwent both tests, and developed triploidy screening based on ES data. ES identified most clinically relevant CNVs, with a 98.91% concordance for regions adequately captured. A retrospective analysis of CNVs detected from ES over a ~3‐year period, comprising 1563 prenatal and 4884 postnatal cases, revealed CNVs in 3.8% of prenatal and 4.4% of postnatal samples. The relatively low percentage stems from the fact that most cases underwent CMA before ES. Pathogenic or likely pathogenic variants constituted 78.7% and 78.0% of these subgroups, with the remainder classified as variants of unknown significance. We highlight clinically relevant examples of CNVs across a range of sizes, including cases involving both CNVs and SNVs. The high consanguinity rate of the cohort allowed for systematic analysis of homozygous CNVs. Additionally, we demonstrate that ES can capture other diagnostic utilities traditionally associated with CMA, specifically uniparental disomy (UPD) and triploidy. Overall, our findings support ES as a robust, cost‐effective alternative to CMA and advocate for its broader use as a first‐tier diagnostic test for neurodevelopmental delay and congenital malformations, particularly until whole genome sequencing becomes more accessible and affordable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Hadassah Medical Center, Jerusalem, Israel.
- Faculty of Medicine, Hebrew University of Jerusalem, Israel.
ORCID-Profile: Jonathan Rips, Hagit Daum, Hagar Mor-Shaked, Tamar Harel
Zitieren
APA
Birnbaum, R., Slovik, M., Zenvirt, S., Livyatan, I., Altman, I., Gershon, S., Rips, J., Daum, H., Rosenbluh, C., Elpeleg, O., Meiner, V., Frumkin, A., Mor-Shaked, H., & Harel, T. (2026). High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics. Clinical Genetics. https://doi.org/10.1111/cge.70079
Vancouver
Birnbaum R, Slovik M, Zenvirt S, Livyatan I, Altman I, Gershon S, et al. High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics. Clinical Genetics. 2026. doi:10.1111/cge.70079
BibTeX
@article{Birnbaum2026,
author = {Birnbaum, Rivka and Slovik, Maya and Zenvirt, Shamir and Livyatan, Ilana and Altman, Israel and Gershon, Shiri and Rips, Jonathan and Daum, Hagit and Rosenbluh, Chaggai and Elpeleg, Orly and Meiner, Vardiella and Frumkin, Ayala and Mor-Shaked, Hagar and Harel, Tamar},
title = {High Concordance of Copy Number Variants Detected by Chromosomal Microarray and Exome Sequencing in Clinical Diagnostics},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70079}
}
EUVIMED